| Followers | 48 |
| Posts | 23547 |
| Boards Moderated | 0 |
| Alias Born | 09/16/2012 |
Sunday, November 28, 2021 11:30:40 AM
And none of that can effectively be PR'd to avoid selling all their shares at all time lows?
You're basically saying they stalled out for five years of saving lives because of something that cost less than $2 million to develop?? Even with an army of smart h5 technicians under U.S. / UK supervision, somehow couldn't produce DCVAX "affordably" without the $1.4M gadget?
Pseudo progression has been an issue for decades. Any patient and good doctor knows when a tumor is in remission vs. growing. So, how convenient Flaskworks and the new progression detection methods theory moves along all at the same time.
Not buying any of it. Just Google GBM survivors over the last ten years and you'll find a sea of people doing well on all types of treatments, of which DCVAX rarely appears.
You're basically saying they stalled out for five years of saving lives because of something that cost less than $2 million to develop?? Even with an army of smart h5 technicians under U.S. / UK supervision, somehow couldn't produce DCVAX "affordably" without the $1.4M gadget?
Pseudo progression has been an issue for decades. Any patient and good doctor knows when a tumor is in remission vs. growing. So, how convenient Flaskworks and the new progression detection methods theory moves along all at the same time.
Not buying any of it. Just Google GBM survivors over the last ten years and you'll find a sea of people doing well on all types of treatments, of which DCVAX rarely appears.
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
